OTTAWA--(BUSINESS WIRE)--Canada’s biotechnology CEOs are calling for an economic stimulus package that includes targeted measures designed to protect $1.7 billion of annual spending and preserve high-value “21st century” jobs in Canada in the face of a severe economic times. These measures include a one-time cash refund on tax losses, an exemption from capital gains tax on the next two years’ of investment, and changes to the Scientific Research and Experimental Development (SR&ED) credit program to support the sector during the economic downturn.
